Climate Change Data

HBM Partners

Climate Impact & Sustainability Data (2021, 2022-2023, 2023)

Reporting Period: 2021

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance
  • UN Sustainable Development Goals (SDGs)

Environmental Achievements

  • HBM portfolio companies have inherently low carbon emissions and natural resource use due to their R&D focus.

Social Achievements

  • HBM actively contributes to improvements in health and well-being by providing capital to firms within the healthcare industry.
  • HBM promotes diversity in the workplace and is an equal opportunities employer.

Governance Achievements

  • HBM adheres to the highest standards and values of business conduct and implements appropriate preventive procedures against illegal or harmful practices.
  • HBM actively influences its portfolio companies’ strategies with respect to ESG principles through active ownership (proxy voting for public companies and board representation for private companies).

Climate Goals & Targets

Environmental Challenges

  • Lack of standardized and comparable frameworks for measuring ESG/SDG performance leading to greenwashing.
  • Absence of external rating providers for private companies, resulting in reliance on company management information.
Mitigation Strategies
  • HBM monitors developments in regulatory frameworks and investor demand proactively.
  • HBM uses ISS DataDesk and ISS ESG Fund Rating for monthly ESG/SDG performance screening of public portfolio companies.
  • HBM performs semi-annual portfolio reviews for private equity investments, including ESG/SDG related developments.
  • HBM relies on traditional investment parameters when ESG/SDG data is unavailable for non-transparent assets.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SFDR (Sustainable Finance Disclosure Regulation)

UN Sustainable Development Goals

  • 3
  • 5
  • 8
  • 9
  • 10
  • 12
  • 13

HBM's investment in healthcare contributes to several SDGs, particularly those related to health, gender equality, economic growth, innovation, reduced inequalities, responsible consumption, and climate action.

Reporting Period: 2022-2023

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Declining valuations for technology and growth stocks due to inflation and rising interest rates.
  • Strong valuation corrections in the small and medium-sized company segment.
  • Slowing economic growth and restrictive Covid-19 policies in China affecting Cathay Biotech valuation.
  • US FDA denial of marketing approval for omburtamab by portfolio company Y-mAbs Therapeutics.
Mitigation Strategies
  • Four profitable acquisitions (Turning Point Therapeutics, Sierra Oncology, ChemoCentryx, Biohaven Pharmaceuticals).
  • Numerous follow-on investments in existing private companies.
  • Selective expansion of the public company portfolio using favorable valuation levels.
  • Continued distribution policy with a planned yield of 3.5 percent.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2023

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance
  • UN Sustainable Development Goals (SDGs)

Social Achievements

  • Promoting diversity in the workplace
  • Providing capital to firms within the healthcare industry, creating jobs and a dynamic working environment

Governance Achievements

  • Adhering to laws and regulations; implementing preventive procedures against illegal or harmful practices, bribery, corruption, collusion and money laundering
  • Annual training for all employees on HBM policies

Climate Goals & Targets

Environmental Challenges

  • Lack of standardized and comparable frameworks for measuring ESG/SDG performance leading to greenwashing
  • Absence of external rating providers for private companies, resulting in reliance on management information
Mitigation Strategies
  • Closely monitoring developments in regulatory frameworks and investor demand to adapt accordingly
  • Implementing processes exceeding Art. 6 SFDR requirements
  • Considering a potential classification of Art. 8 SFDR if reasonably feasible
  • Relying on traditional parameters for investment decisions and monitoring in the absence of ESG/SDG data for non-transparent assets

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SFDR

UN Sustainable Development Goals

  • Goal 3: Good health and well-being
  • Goal 5: Gender equality
  • Goal 8: Decent work and economic growth
  • Goal 9: Industry, innovation and infrastructure
  • Goal 10: Reduced inequalities
  • Goal 12: Responsible consumption and production
  • Goal 13: Climate action

HBM's investment in healthcare contributes to improving health and well-being; active ownership influences portfolio companies' strategies regarding gender equality, decent work, responsible consumption, climate action, and reducing inequalities; investments promote industry innovation and infrastructure.